智通财经APP讯，东曜药业-B(01875)公布，公司用作于联交所买卖股份的英文股份简称将由“TOT BIOPHARM-B”更改为“BIODLINK-B”，自2025年7月30日上午九时正起生效。公司中文股份简称“东曜药业-B”及股份代号“1875”维持不变。
智通财经APP讯，东曜药业-B(01875)公布，公司用作于联交所买卖股份的英文股份简称将由“TOT BIOPHARM-B”更改为“BIODLINK-B”，自2025年7月30日上午九时正起生效。公司中文股份简称“东曜药业-B”及股份代号“1875”维持不变。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.